Furthermore, the use of antidiabetic medications that mitigate acute glucose variations, such as glinides, alpha-glucosidase inhibitors, and DPP-4 inhibitors, as well as those that enhance insulin sensitivity, including thiazolidinediones and metformin, are anticipated to positively influence endothelial function in patients with DM. This evidence concerns the gene DPP4 and diabetes mellitus.